Related content

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease

By Toledo Jon   Korff Ane   Shaw Leslie   Trojanowski John   Zhang Jing  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 683-697

Springer Publishing Company

Access to resources Recommend Favorite

CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodies

By Bibl M.   Mollenhauer B.   Esselmann H.   Lewczuk P.   Trenkwalder C.   Brechlin P.   Rüther E.   Kornhuber J.   Otto M.   Wiltfang J.  

Journal of Neural Transmission, Vol. 113, Iss. 11, 2006-11 ,pp. : 1771-1778

Springer Publishing Company

Access to resources Recommend Favorite

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia

By Laske Christoph  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 80-85

Springer Publishing Company

Access to resources Recommend Favorite

Apo-Eε4 Allele in Conjunction with A&bgr;42 and Tau in CSF: Biomarker for Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 8, Iss. 2, 2011-03 ,pp. : 187-196

Bentham Science Publishers

Access to resources Recommend Favorite

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

By Hu William   Chen-Plotkin Alice   Arnold Steven   Grossman Murray   Clark Christopher   Shaw Leslie   Pickering Eve   Kuhn Max   Chen Yu   McCluskey Leo   Elman Lauren   Karlawish Jason   Hurtig Howard   Siderowf Andrew   Lee Virginia   Soares Holly   Trojanowski John  

Acta Neuropathologica, Vol. 119, Iss. 6, 2010-06 ,pp. : 669-678

Springer Publishing Company

Access to resources Recommend Favorite